» Articles » PMID: 30208739

Roles of MiR-200 Family Members in Lung Cancer: More Than Tumor Suppressors

Overview
Journal Future Oncol
Specialty Oncology
Date 2018 Sep 14
PMID 30208739
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs are a class of single-stranded noncoding RNAs, which have no coding potential, but modulate many molecular mechanisms including cancer pathogenesis. miRNAs participate in cell proliferation, differentiation, apoptosis, as well as carcinogenesis or cancer progression, and their involvement in lung cancer has been recently shown. They are suggested to have bidirectional functions on important cancer-related genes so as to enhance or attenuate tumor genesis. Epithelial-mesenchymal transition (EMT) is a fundamental process which contributes to integrity of organogenesis and tissue differentiation as well as tissue repair, organ fibrosis and the progression of carcinoma, and several miRNAs were suggested to form the network regulating EMT in lung cancer, among which, miR-200 family members (miR-200a, miR-200b, miR-200c, miR-429 and miR-141) play crucial roles in the suppression of EMT.

Citing Articles

Diagnostic value of microRNA-200 expression in peripheral blood-derived extracellular vesicles in early-stage non-small cell lung cancer.

Liu L, Zhang F, Niu D, Guo X, Lei T, Liu H Clin Exp Med. 2024; 24(1):214.

PMID: 39249157 PMC: 11384644. DOI: 10.1007/s10238-024-01455-4.


Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


Diagnostic value of miR-200 family in non-small cell lung cancer: a meta-analysis.

Ling Z, Yang L Biomark Med. 2024; 18(8):419-431.

PMID: 39041844 PMC: 11285352. DOI: 10.2217/bmm-2024-0087.


Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review.

Sadeghi M, Lotfi M, Soltani N, Farmani E, Fernandez J, Akhlaghitehrani S Cancer Cell Int. 2023; 23(1):284.

PMID: 37986065 PMC: 10661689. DOI: 10.1186/s12935-023-03133-z.


MicroRNAs in cancer metastasis: biological and therapeutic implications.

Sell M, Ramlogan-Steel C, Steel J, Dhungel B Expert Rev Mol Med. 2023; 25:e14.

PMID: 36927814 PMC: 10407223. DOI: 10.1017/erm.2023.7.